Medical treatment of miscarriage using misoprostol-a retrospective study.
Double endometrial stripe thickness
Early miscarriage
Misoprostol
Missed abortion
Journal
Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213
Informations de publication
Date de publication:
13 Aug 2024
13 Aug 2024
Historique:
received:
01
03
2024
accepted:
01
07
2024
medline:
13
8
2024
pubmed:
13
8
2024
entrez:
13
8
2024
Statut:
aheadofprint
Résumé
The treatment of early miscarriage with medication is effective and low in side effects. Nevertheless, no uniform dosage regimen has yet been established, nor has it been possible to determine whether previous pregnancies and births with their respective modes of delivery play a role in the effectiveness of Misoprostol. This study aimed to find predictive parameters for successful treatment with Misoprostol in early miscarriage. In a retrospective study at the Otto von Guericke University Women's Hospital, records of patients with early miscarriage and medical treatment using Misoprostol from 2018 to 2021 were reviewed for this purpose. The need for a curettage subsequent to treatment was scored as a parameter of failure. The data were analyzed using Statistical Package for the Social Science Version 28.0. The significance level was set to 0.050. We found that successful therapy with misoprostol was seen in 86% (n = 114). 14% (n = 20) of the patients had curettage after taking Misoprostol as advised. Out of 134 women, 16% (n = 21) reported mild side effects, with nausea as the leading one (9.2% (n = 12)). Significance was found comparing the measurement of double endometrial stripe thickness after the second cycle of Misoprostol in women with and without curettage after medical treatment (exact value two-sided 0.035 at p < 0.05). A cutoff value at 8.8 mm was calculated using ROC Analysis. Our results indicate that the treatment of early miscarriage in the first trimester with Misoprostol is effective and has few side effects. The measurement of the endometrial stripe thickness after the second cycle of Misoprostol via transvaginal ultrasound could present a predictive marker during therapy.
Identifiants
pubmed: 39136729
doi: 10.1007/s00404-024-07628-6
pii: 10.1007/s00404-024-07628-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Magnus MC, Wilcox AJ, Morken N-H et al (2019) Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ 1869. https://doi.org/10.1136/bmj.l869
doi: 10.1136/bmj.l869
Abortion care guideline (2022) World health organization. Human Reproduction Programme, Geneva
Ballagh SA, Harris HA, Demasio K (1998) Is curettage needed for uncomplicated incomplete spontaneous abortion? Am J Obstet Gynecol 179:1279–1282. https://doi.org/10.1016/S0002-9378(98)70147-4
doi: 10.1016/S0002-9378(98)70147-4
pubmed: 9822516
Griebel CP, Halvorsen J, Golemon TB, Day AA (2005) Management of spontaneous abortion. Am Fam Physician 72:1243–1250
pubmed: 16225027
Niino Y (2011) The increasing cesarean rate globally and what we can do about it. Biosci Trends 5:139–150. https://doi.org/10.5582/bst.2011.v5.4.139
doi: 10.5582/bst.2011.v5.4.139
pubmed: 21914948
Journal für Reproduktionsmedizin und Endokrinologie Journal of Reproductive Medicine and Endocrinology (2019) German IVF Register 2019, https://www.deutsches-ivf-register.de/perch/resources/dir-jahrbuch-2019-de.pdf . Accessed 20 Feb 2023
Hooker AB, Lemmers M, Thurkow AL et al (2014) Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update 20:262–278. https://doi.org/10.1093/humupd/dmt045
doi: 10.1093/humupd/dmt045
pubmed: 24082042
Sevinç F, Oskovi-Kaplan ZA, Çelen Ş et al (2021) Identifying the risk factors and incidence of asherman syndrome in women with p OST-ABORTION uterine curettage. J Obstet Gynaecol Res 47:1549–1555. https://doi.org/10.1111/jog.14667
doi: 10.1111/jog.14667
pubmed: 33462894
Chu JJ, Devall AJ, Beeson LE et al (2020) Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial. The Lancet 396:770–778. https://doi.org/10.1016/S0140-6736(20)31788-8
doi: 10.1016/S0140-6736(20)31788-8
Raymond EG, Harrison MS, Weaver MA (2019) Efficacy of misoprostol alone for first-trimester medical abortion: a systematic review. Obstet Gynecol 133:137–147. https://doi.org/10.1097/AOG.0000000000003017
doi: 10.1097/AOG.0000000000003017
pubmed: 30531568
pmcid: 6309472
Kim C, Barnard S, Neilson JP et al (2017) Medical treatments for incomplete miscarriage. Cochrane Database Systematic Rev. https://doi.org/10.1002/14651858.CD007223.pub4
doi: 10.1002/14651858.CD007223.pub4
Zhang J, Zhou K, Shan D, Luo X (2022) Medical methods for first trimester abortion. Cochrane Database Systematic Rev. https://doi.org/10.1002/14651858.CD002855.pub5
doi: 10.1002/14651858.CD002855.pub5
Abubeker FA, Lavelanet A, Rodriguez MI, Kim C (2020) Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review. BMC Womens Health 20:142. https://doi.org/10.1186/s12905-020-01003-8
doi: 10.1186/s12905-020-01003-8
pubmed: 32635921
pmcid: 7339463
Musik T, Grimm J, Juhasz-Böss I, Bäz E (2021) Treatment options after a diagnosis of early miscarriage: expectant, medical, and surgical. Deutsch Aerzteblatt Online. https://doi.org/10.3238/arztebl.m2021.0346
doi: 10.3238/arztebl.m2021.0346
World Health Organization (2022) Medical management of abortion https://books.google.de/books?hl=en&lr=&id=kHOyDwAAQBAJ&oi=fnd&pg=PR4&ots=1XDRnbNmZZ&sig=OUIjQUuBLOFg_eaN0xdcKd84Om0&redir_esc=y#v=onepage&q&f=false(letzter Zugriff 30.3.2022)
AWMF: Geburtseinleitung (2022) Leitline der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. AWMF-Registernummer 015–088. Stand Dezember 2020, Addendum vom März 2021 (Version 1.1) https://www.awmf.org/uploads/tx_szleitlinien/015-088ladd_S2k_Geburtseinleitung_2021-04.pdf(letzter Zugriff 31.3.2022)
International Federation of Gynecology and Obstetrics (FIGO) (2017) Misoprostol-only recommended regimens www.mhtf.org/2017/06/29/new-figo-guidelines-for-misoprostol-use(letzter Zugriff 31.3.2022)
National Institute for Health and Care Excellence (NICE) (2019) NICE guideline. Ectopic pregnancy and miscarriage: diagnosis and initial management. https://www.nice.org.uk/guidance/ng126/chapter/Recommendations#management-of-miscarriage(letzter Zugriff 31.3.2022)
Abdelshafy A, Awwad H, Abo-Gamra A et al (2019) Sublingual vs vaginal misoprostol for completion of first trimester missed abortion: a randomised controlled trial. Eur J Contracept Reprod Health Care 24:134–139. https://doi.org/10.1080/13625187.2019.1569224
doi: 10.1080/13625187.2019.1569224
pubmed: 30747547
Pang MW, Lee TS, Chung TK (2001) Incomplete miscarriage: a randomized controlled trial comparing oral with vaginal misoprostol for medical evacuation. Hum Reprod 16:2283–2287. https://doi.org/10.1093/humrep/16.11.2283
doi: 10.1093/humrep/16.11.2283
pubmed: 11679505
Aiken A, Lohr P, Lord J et al (2021) Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study. BJOG 128:1464–1474. https://doi.org/10.1111/1471-0528.16668
doi: 10.1111/1471-0528.16668
pubmed: 33605016
pmcid: 8360126
Menager N-E, Loundou D-A, Chau C et al (2012) Facteurs cliniques et échographiques influençant le succès du misoprostol pour grossesse arrêtée au premier trimestre. Gynecol Obstet Fertil 40:84–87. https://doi.org/10.1016/j.gyobfe.2011.07.047
doi: 10.1016/j.gyobfe.2011.07.047
pubmed: 22154140
Ali MK, Emam SM, Abdel-Aleem MA, Sobh AMA (2021) Misoprostol versus expectant management in women with incomplete first-trimester miscarriage after failed primary misoprostol treatment: a randomized clinical trial. Int J Gynecol Obstet 154:558–564. https://doi.org/10.1002/ijgo.13652
doi: 10.1002/ijgo.13652
Lu Y, Su R, Chen R et al (2022) Predictor assessment of complete miscarriage after medical treatment for early pregnancy loss in women with previous cesarean section. Medicine 101:e31180. https://doi.org/10.1097/MD.0000000000031180
doi: 10.1097/MD.0000000000031180
pubmed: 36254024
pmcid: 9575734
Kamaya A, Krishnarao PM, Nayak N et al (2016) Clinical and imaging predictors of management in retained products of conception. Abdom Radiol 41:2429–2434. https://doi.org/10.1007/s00261-016-0954-x
doi: 10.1007/s00261-016-0954-x